Trial
NCT02198209
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Cedars-Sinai Medical Center
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Liraglutide
Why stopped
Investigator decided not to move forward with study prior to study start date
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-30